Neurophoenix is a preclinical stage biotech company advancing its rabies virus biomimicry based PTEN inactivation compounds to unlock neuron repair in optic neuropathies (NAION, glaucoma) and several other neuronal diseases.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 2, Hameau D'alleray, Paris,75015,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- neurophoenix.fr
- Keywords
- Neurology, glaucoma, NAION, neuroprotection, Neurodegenerative disease, ALS, R&D, Motoneuron Disease.
- HQ
- Paris
Neurophoenix Questions
Neurophoenix's website is neurophoenix.fr
Neurophoenix's LinkedIn profile is https://fr.linkedin.com/company/neurophoenix
Neurophoenix has
2 employees.
View email and phone details for 2
employees at Neurophoenix.
Neurophoenix's industry is
Biotechnology Research
Neurophoenix's top competitors are
The Serious Gut,
Diaorigin Biotechnology,
Erypharm,
Telomium,
Vaxon Biotech,
Whitelab Genomics,
Miltenyi Biotec,
Carthera,
Biophta,
Diotheris.
Neurophoenix's categories are Biotechnology Research
Neurophoenix's founding year is 2018
